Concepedia

Jia Yi Fong

JY

Statistics

Publications

4

Citations

398

H-Index

4

Active since

2019

Affiliations

Agency for Science, Technology and Research(Current)

Icahn School of Medicine at Mount Sinai

Experimental Drug Development Centre

Institute of Molecular and Cell Biology

National University of Singapore

Jia Yi Fong is an author at Agency for Science, Technology and Research specializing in pharmacology, peptidomimetic design, and molecular biology.

ORCID

Publications per year

2019–2022

4

Publications

4

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

Jia Yi Fong, Luca Pignata, Pierre-Alexis Goy et al. · Cancer Cell · 2019 · 279 citations · Full text

, , +16

PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis

Slim Mzoughi, Jia Yi Fong, David Papadopoli et al. · Nature Communications · 2020 · 49 citations · Full text

, , +12

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir

Subramanyam Vankadara, Monique Danielle Dawson, Jia Yi Fong et al. · ACS Medicinal Chemistry Letters · 2022 · 42 citations · Full text

, , +17

A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors

Subramanyam Vankadara, Yun Xuan Wong, Yi Yang See et al. · Bioorganic & Medicinal Chemistry Letters · 2021 · 28 citations · Full text

, , +7

1–4 of 4